Stock Analysts’ Updated EPS Estimates for September 2nd (ADM, ALEX, ALNY, ARWR, ASO, BATS, BRBY, BTI, CANF, CRM)

Stock Analysts’ updated eps estimates for Tuesday, September 2nd:

Admiral Group (LON:ADM) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 4,100 price target on the stock.

Alexander & Baldwin (NYSE:ALEX) had its market perform rating reaffirmed by analysts at JMP Securities.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $570.00 price target on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reissued by analysts at HC Wainwright. They currently have a $80.00 target price on the stock.

Academy Sports and Outdoors (NASDAQ:ASO) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $65.00 price target on the stock.

British American Tobacco (LON:BATS) was downgraded by analysts at Royal Bank Of Canada to an underperform rating. The firm currently has GBX 3,400 price target on the stock, up from their previous price target of GBX 3,000.

Burberry Group (LON:BRBY) had its buy rating reaffirmed by analysts at HSBC Holdings plc. HSBC Holdings plc currently has a GBX 1,600 price target on the stock.

British American Tobacco (NYSE:BTI) was downgraded by analysts at Royal Bank Of Canada from a sector perform rating to an underperform rating.

Can-Fite BioPharma (NYSE:CANF) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $11.00 target price on the stock.

Salesforce (NYSE:CRM) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $430.00 price target on the stock.

Cytokinetics (NASDAQ:CYTK) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $78.00 price target on the stock.

Cytokinetics (NASDAQ:CYTK) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $72.00 price target on the stock.

DiaMedica Therapeutics (NASDAQ:DMAC) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Darden Restaurants (NYSE:DRI) had its buy rating reiterated by analysts at Truist Financial Corporation. The firm currently has a $252.00 target price on the stock.

Dynatrace (NYSE:DT) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

DoubleVerify (NYSE:DV) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $20.00 target price on the stock.

ENI (NYSE:E) had its sector perform rating reissued by analysts at Royal Bank Of Canada.

Ecora Resources (LON:ECOR) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 150 target price on the stock.

Eledon Pharmaceuticals (NASDAQ:ELDN) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.00 price target on the stock.

e.l.f. Beauty (NYSE:ELF) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating. Deutsche Bank Aktiengesellschaft currently has $128.00 price target on the stock.

Enlivex Therapeutics (NASDAQ:ENLV) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $7.00 target price on the stock.

Everplay Group (LON:EVPL) had its buy rating reiterated by analysts at Shore Capital.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) had its sell rating reissued by analysts at UBS Group AG.

Fortinet (NASDAQ:FTNT) had its underweight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $67.00 price target on the stock, down from their previous price target of $78.00.

Fortive (NYSE:FTV) had its equal weight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $50.00 target price on the stock, down from their previous target price of $90.00.

G-III Apparel Group (NASDAQ:GIII) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $27.00 target price on the stock.

HudBay Minerals (NYSE:HBM) (TSE:HBM) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Hiscox (LON:HSX) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a GBX 1,400 target price on the stock.

Hunting (LON:HTG) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a GBX 440 price target on the stock.

Intuit (NASDAQ:INTU) had its outperform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $850.00 price target on the stock.

IREN (NASDAQ:IREN) had its hold rating reaffirmed by analysts at Jones Trading.

Ithaca Energy (LON:ITH) had its no recommendation rating reissued by analysts at Shore Capital.

JTC (LON:JTC) had its hold rating reaffirmed by analysts at Shore Capital. The firm currently has a GBX 1,200 target price on the stock.

Kiora Pharmaceuticals (NASDAQ:KPRX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $10.00 target price on the stock.

Legal & General Group (LON:LGEN) had its underperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 200 target price on the stock.

Lam Research (NASDAQ:LRCX) had its underweight rating reaffirmed by analysts at Morgan Stanley. They currently have a $92.00 target price on the stock, down from their previous target price of $94.00.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $4.00 price target on the stock.

MongoDB (NASDAQ:MDB) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $350.00 price target on the stock.

Medicus Pharma (NASDAQ:MDCX) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $27.00 price target on the stock.

Microvision (NASDAQ:MVIS) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $3.00 target price on the stock.

MaxLinear (NASDAQ:MXL) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $25.00 target price on the stock.

Oxford Nanopore Technologies (LON:ONT) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 250 price target on the stock.

OS Therapies (NYSE:OSTX) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $20.00 price target on the stock.

Pinterest (NYSE:PINS) had its buy rating reiterated by analysts at Guggenheim.

Permian Resources (NYSE:PR) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a $17.00 target price on the stock.

Porch Group (NASDAQ:PRCH) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $20.00 price target on the stock.

Roku (NASDAQ:ROKU) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $110.00 target price on the stock.

Signet Jewelers (NYSE:SIG) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $92.00 target price on the stock.

Summit Therapeutics (NASDAQ:SMMT) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $50.00 price target on the stock.

Synovus Financial (NYSE:SNV) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating. They currently have $56.00 price target on the stock, down from their previous price target of $63.00.

Simon Property Group (NYSE:SPG) was downgraded by analysts at Stifel Nicolaus from a buy rating to a hold rating. They currently have $179.00 price target on the stock.

Tenaya Therapeutics (NASDAQ:TNYA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $5.00 target price on the stock.

Valaris (NYSE:VAL) was downgraded by analysts at Clarkson Capital from a buy rating to a neutral rating. The firm currently has $54.00 target price on the stock.

Vivani Medical (NASDAQ:VANI) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.

Veritone (NASDAQ:VERI) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $6.00 price target on the stock.

Petco Health and Wellness (NASDAQ:WOOF) had its neutral rating reissued by analysts at Guggenheim.

Xenon Pharmaceuticals (NASDAQ:XENE) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $55.00 target price on the stock.

Xencor (NASDAQ:XNCR) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $26.00 price target on the stock.

Block (NYSE:XYZ) was downgraded by analysts at BNP Paribas Exane from an outperform rating to a neutral rating. They currently have $86.00 price target on the stock.